Clinical Challenges: Nuclear Medicine and Biochemically Recurrent Prostate Cancer
With the advent of fluciclovine and PSMA, nuclear medicine has carved out a key role in the visualization of prostate... Read More
Prostate Cancer Subtype that Responds to Immunotherapy Identified
Investigators from the U.S. and U.K. have identified a subtype of prostate cancer that may respond to immune checkpoint inhibitor... Read More